Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS banner

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
IST:ANGEN.E

Watchlist Manager
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS Logo
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
IST:ANGEN.E
Watchlist
Price: 10.2 TRY Market Closed
Market Cap: ₺2.2B

Cash Flow Statement

Cash Flow Statement
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS

Rotate your device to view
Cash Flow Statement
Currency: TRY
Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Operating Cash Flow
Net Income
485
348
443
612
443
532
336
180
172
123
(95)
(202)
(286)
(219)
(241)
(313)
(326)
(313)
Depreciation & Amortization
9
7
10
12
10
16
60
27
32
27
16
39
51
143
112
124
152
148
Other Non-Cash Items
28
14
(38)
(3)
1
(4)
(86)
(139)
(43)
(34)
58
3
92
240
240
181
194
265
Cash Taxes Paid
32
39
23
19
23
6
0
13
0
15
1
7
0
0
(2)
(0)
(0)
(0)
Cash Interest Paid
1
2
0
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(118)
(103)
(8)
(97)
(64)
(36)
(99)
34
5
(16)
36
110
72
(87)
(106)
(83)
(77)
87
Cash from Operating Activities
404
N/A
267
-34%
407
+53%
524
+29%
390
-26%
508
+30%
(135)
N/A
102
N/A
166
+63%
100
-39%
15
-85%
(87)
N/A
(70)
+19%
10
N/A
5
-54%
(54)
N/A
(58)
-7%
187
N/A
Investing Cash Flow
Capital Expenditures
(103)
(93)
(77)
(101)
(77)
(96)
(141)
(91)
(99)
(105)
(73)
(100)
(107)
(323)
(174)
(254)
(265)
(436)
Other Items
(238)
79
10
(29)
(29)
(190)
(71)
(41)
178
67
15
34
6
26
4
16
15
9
Cash from Investing Activities
(341)
N/A
(14)
+96%
(67)
-390%
(130)
-93%
(106)
+18%
(286)
-169%
(212)
+26%
(132)
+38%
78
N/A
(37)
N/A
(57)
-54%
(67)
-16%
(102)
-53%
(297)
-191%
(171)
+42%
(239)
-40%
(250)
-5%
(427)
-71%
Financing Cash Flow
Net Issuance of Common Stock
0
0
225
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Issuance of Debt
26
5
(26)
(26)
(26)
(4)
11
(5)
1
2
(2)
(17)
(14)
(15)
19
61
58
90
Cash Paid for Dividends
0
0
(210)
0
0
(306)
(585)
0
(436)
(130)
0
0
0
0
0
0
0
0
Other
(201)
(268)
(2)
(157)
(156)
55
28
6
153
17
(5)
2
(14)
0
(1)
1
(1)
(15)
Cash from Financing Activities
(175)
N/A
(263)
-50%
(13)
+95%
43
N/A
43
+0%
(30)
N/A
(545)
-1 738%
(305)
+44%
(282)
+7%
(111)
+61%
(7)
+94%
115
N/A
101
-12%
(15)
N/A
18
N/A
62
+251%
58
-7%
75
+29%
Change in Cash
Net Change in Cash
(113)
N/A
(10)
+91%
327
N/A
437
+34%
327
-25%
192
-41%
(893)
N/A
(335)
+62%
(38)
+89%
(48)
-27%
(50)
-4%
(39)
+23%
(71)
-84%
(302)
-325%
(149)
+51%
(231)
-55%
(250)
-8%
(166)
+34%
Free Cash Flow
Free Cash Flow
301
N/A
174
-42%
330
+90%
423
+28%
313
-26%
412
+32%
(277)
N/A
11
N/A
66
+507%
(4)
N/A
(58)
-1 221%
(187)
-222%
(178)
+5%
(313)
-76%
(169)
+46%
(308)
-82%
(323)
-5%
(249)
+23%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett